

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | C$0.73 | C$377.39 C$264.18 | |
| 270 pills | C$0.85 | C$327.81 C$229.46 | |
| 180 pills | C$0.91 | C$234.14 C$163.90 | |
| 120 pills | C$1.06 | C$181.80 C$127.26 | |
| 90 pills | C$1.23 | C$159.76 C$111.83 | |
| 60 pills | C$1.41 | C$121.19 C$84.83 | |
| 30 pills | C$2.51 | C$107.41 C$75.19 | |
| 20 pills | C$3.47 | C$99.15 C$69.40 | |
| 360 pills | C$1.16 | C$595.03 C$416.52 Free shipping | |
| 270 pills | C$1.25 | C$484.83 C$339.38 Free shipping | |
| 180 pills | C$1.39 | C$358.11 C$250.68 | |
| 120 pills | C$1.50 | C$258.93 C$181.25 | |
| 90 pills | C$1.62 | C$209.34 C$146.54 | |
| 60 pills | C$1.77 | C$151.49 C$106.04 | |
| 30 pills | C$1.87 | C$79.86 C$55.91 | |
| 20 pills | C$2.22 | C$63.34 C$44.33 |
Disclaimer: This patient information leaflet provides general information. It should not replace medical advice from a licensed clinician or pharmacist. Always follow the instructions given by the treating physician and the pharmacist.
Breast cancer is among the most common cancers affecting women worldwide. The growth of some breast cancers depends on estrogen signaling, which can drive tumor cells through estrogen receptors.
Nolvadex is a brand name for tamoxifen citrate, a selective estrogen receptor modulator (SERM). A SERM binds to estrogen receptors and can block or mimic estrogen effects depending on the tissue. In breast tissue, tamoxifen mainly blocks estrogen activity, helping to slow or stop cancer cell growth (estrogen receptor antagonism in the breast).
Nolvadex is prescribed under medical supervision and may be used in treatment plans that aim to reduce cancer progression or recurrence. Its use may be part of an adjuvant strategy after surgery, chemotherapy, or radiation, or for prevention in some high-risk individuals. Availability and use may vary by province or territory and may require a prescription depending on local rules.
The pharmacologic action of Nolvadex involves binding to estrogen receptors with tissue-selective effects. In addition to breast tissue, effects in other tissues (such as bone, liver, or uterus) may differ from those in the breast. These tissue-specific actions are considered when weighing benefits and potential risks in each patient.
Understanding the mechanism helps explain why routine monitoring and follow-up are recommended during therapy. If questions arise about how tamoxifen works in a specific clinical context, consultation with the prescribing clinician or pharmacist is advised.
Nolvadex is prescribed for certain estrogen receptor–positive breast cancers in adults, including women and men, when approved by clinical guidelines. It may be used as part of treatment to reduce the risk of cancer recurrence after initial therapy, or for ongoing management of advanced or metastatic disease in selected cases.
In some settings, Nolvadex may be used to reduce the risk of developing breast cancer in individuals at high risk, though this preventive use depends on clinician assessment and local guidelines. The aim is to lower the likelihood of cancer developing or progressing by modulating estrogen signaling in breast tissue.
During treatment, the goal is to balance cancer control with potential side effects. The exact plan, including duration of therapy and need for additional treatments, is determined by the treating physician after evaluation of tumor characteristics, patient health, and treatment response.
Genetic, hormonal, and lifestyle factors influence response to therapy. If more information is needed about how Nolvadex applies to a specific cancer type or stage, inquiries should be directed to the oncology team or a pharmacist familiar with the local formulary.
Establishing expectations about long-term benefit requires regular assessment, as responses can vary between individuals and over time. Continuous communication with the healthcare team is encouraged to optimize safety and effectiveness.
Before starting Nolvadex, a healthcare professional will review the patient’s medical history, current medications, and potential drug interactions. This review helps identify any contraindications or precautions that may apply.
A formal prescription is typically required, with appropriate counseling provided by the pharmacist or prescriber. In Canada, local prescribing rules may vary by province or territory and by the specific clinical indication. Check with a healthcare professional if there is any doubt about requirement or access.
Baseline assessments may be requested, including laboratory tests and medical history checks. Information about menstrual status, pregnancy potential, and breastfeeding status is important and will influence risk assessment and monitoring plans.
All medications and supplements being taken should be disclosed to the clinician. Any known allergies, prior adverse reactions, and current symptoms should be documented to support safe use of Nolvadex.
The patient information leaflet provided with the medication contains product-specific details, including the brand name, generic name, and lot information. It should be kept for reference and reviewed at refills or if any questions arise.
The initial consultation confirms the indication for Nolvadex and establishes the treatment goals. The clinician explains how the medication fits into the overall cancer care plan and what monitoring will be required.
Important discussions cover potential benefits, common side effects, and warning signs that would require medical attention. Patients are advised to report any unusual symptoms promptly to the clinical team or pharmacist.
A complete list of all prescription medicines, over-the-counter drugs, and supplements is reviewed for potential interactions. Certain medicines may interact with Nolvadex or affect how it is absorbed, distributed, or eliminated from the body.
Allergies, particularly to tamoxifen or related compounds, are documented to prevent adverse reactions. If a history of blood clots exists, risk discussions will be emphasized during planning.
A schedule for follow-up appointments, laboratory tests, and imaging studies is established. Monitoring often includes checks of liver function, blood counts, and other markers as indicated by the treatment plan.
Instructions about when to seek urgent medical help are provided. Patients are advised to contact the healthcare team if new or worsening symptoms occur between visits.
Daily intake should follow the exact instructions provided by the clinician. The medication is typically taken by mouth with water. It may be taken with or without food unless instructed otherwise by the clinician or pharmacist.
Timing consistency is encouraged to maintain steady drug levels. If a dosing schedule is provided, it should be followed as closely as possible to maximize potential benefit and minimize variability in exposure.
Tablets must be swallowed whole unless there is a specific instruction to modify the form. Do not crush or chew the tablets unless explicitly advised by a healthcare professional. If a dose is missed, guidance from a clinician should be followed; generally, the next dose should be taken at the usual time, without doubling up doses.
A pharmacist can provide specific advice about taking Nolvadex with other prescribed medications or with OTC products. Certain products or supplements may require adjustments to timing or monitoring, and professional input is advised before combining therapies.
Taking Nolvadex at a consistent time each day helps maintain stable blood levels of the medicine. If a dose is missed, the plan for catching up or skipping the dose is determined by the clinician or pharmacist.
Practical routines can be written down or stored in a reminder app to support adherence. Consistency reduces the risk of missing doses and helps sustain treatment effects.
Food intake generally does not require strict timing relative to Nolvadex unless symptoms suggest otherwise. Some patients notice improved tolerance when taken with meals, while others prefer fasting schedules; any changes should be discussed with the care team.
Alcohol consumption and certain herbal products may influence liver function or interact with medications. Consult the clinician about any planned changes in diet, alcohol use, or supplement intake during Nolvadex therapy.
If a dose is missed, consult the clinician or pharmacist for specific instructions. In many cases, the missed dose should be taken as soon as remembered unless it is close to the time for the next dose.
Do not take two doses at the same time to compensate for a missed dose. Doubling up can increase the risk of adverse effects. If vomiting occurs after a dose, contact a clinician for guidance about the next steps.
When traveling, keep Nolvadex in its original packaging to protect from light and moisture. Carry a copy of the prescription or contact information for the prescribing clinician in case of questions at border controls or pharmacies abroad.
Ensure adequate supply during trips and time zone changes. If a dose timing is significantly disrupted, consult the healthcare team for advice on maintaining treatment continuity.
Responses to Nolvadex vary between individuals. In many cases, early effects on tumor activity are not immediately visible to the patient, while some patients may notice mood, energy, or bodily changes over weeks to months.
Common early experiences can include hot flashes, night sweats, fatigue, and mild nausea. Temporary changes in menstrual patterns or vaginal discharge may occur in some patients, though these effects are not universal.
Bone health, cardiovascular risk, and metabolic effects are considered during treatment planning. The healthcare team may order tests to monitor function and to assess tolerance to therapy over time.
Any new or concerning symptoms, persistent severe side effects, or signs suggesting an allergic reaction should be reported promptly. The aim is to maintain safety while pursuing potential cancer-control benefits.
Patients should be advised that improvements in cancer-related outcomes do not occur immediately and may require several weeks to months of therapy. Ongoing evaluation by the clinical team is essential to determine duration and adjustments of treatment.
Regular follow-up appointments are scheduled to monitor response to therapy and identify adverse events early. Laboratory tests and imaging studies may be used to assess treatment effects and organ function.
Urgent medical contact is advised for signs of serious conditions, such as sudden chest pain, trouble breathing, severe swelling in the legs, abdominal or pelvic pain, heavy or unusual vaginal bleeding, yellowing of the skin or eyes, or severe headaches with visual changes. Seek prompt medical help if these occur.
Any new medications, including OTC products or supplements, should be discussed with a clinician to avoid potential interactions. Changes in health status, such as liver disease or a history of blood clots, must be communicated to the care team.
Dental and other medical procedures may require special considerations. It is important to inform all healthcare providers about Nolvadex therapy before undergoing surgery or dental work, to plan for bleeding risk and medication interactions.
Store Nolvadex at room temperature, protected from excessive moisture and heat. Do not store in the bathroom or far from the original packaging. The medication should be kept out of reach of children and pets.
Keep the container tightly closed when not in use. Do not use Nolvadex beyond the expiry date printed on the package. If the medication is exposed to heat, moisture, or if there is any doubt about its integrity, consult a pharmacist for guidance on disposal or replacement.
Unused or expired tablets should be disposed of according to local regulations. Do not flush medications down the toilet unless local guidelines approve this method. A pharmacist can provide safe disposal recommendations.
A copy of the patient information leaflet and the prescription label should be kept for reference. Any questions about storage or handling may be directed to a pharmacist or clinician.
Major contraindications include pregnancy and breastfeeding status, along with any known hypersensitivity to tamoxifen or related compounds. If pregnancy is possible, alternative options should be discussed with the clinician.
Caution is advised in individuals with a history of venous thromboembolism (blood clots), liver impairment, or significant liver disease. The risk profile varies among patients and requires careful assessment by the treating team.
Interactions with other medicines may occur. Some antidepressants, antifungals, or other hormonal therapies can influence Nolvadex activity or metabolism. A comprehensive medication review is advised before initiating therapy and whenever new medicines are started.
Special attention is given to interactions with anticoagulants, certain diabetes medications, and agents that affect estrogen signaling. The clinician or pharmacist will provide guidance based on the complete medication list and health status.
Contraception is a consideration in patients of reproductive potential. The use of reliable contraception may be discussed, and alternatives may be recommended during Nolvadex therapy. If pregnancy occurs, immediate medical consultation is advised.
This section provides practical information on common concerns. The answers emphasize safety, real-world use, and how to handle everyday situations while on Nolvadex.
For all questions, consult the official patient leaflet, the prescribing clinician, or the pharmacist if more detail is required. The information here is not a substitute for professional care.
Yes, Nolvadex can be taken with adjustments for travel. It is important to maintain a close-to-usual dosing interval whenever possible. If a schedule is disrupted, contact the healthcare team for guidance on resuming a consistent routine.
In many scenarios, the missed dose should be taken as soon as remembered unless it is near the time for the next dose. Do not double doses to catch up. If there is uncertainty, reach out to a pharmacist or clinician for instruction.
Most routine OTC products can be used as directed, but potential interactions exist. A clinician or pharmacist should review all OTC products for compatibility with Nolvadex, particularly if liver function or bleeding risk is a concern.
Switching therapies is guided by the treating team. A transition plan may include monitoring and adjustments to other treatments, with consideration given to timing and potential interactions.
Benefits are generally assessed over weeks to months, and individual response can vary. The absence of immediate improvement does not indicate failure of therapy; ongoing evaluation is part of the treatment plan.
Tablets should be taken whole unless the clinician provides explicit instructions to modify the formulation. Always follow the guidance given by the prescribing clinician or pharmacist.
Yes, dentists should be informed of Nolvadex therapy. Certain dental procedures may carry bleeding risks or require adjustments in care. Coordination with the healthcare team helps ensure safety during dental work.
Reproductive effects can occur, and counseling is advised for individuals planning pregnancy or who are of childbearing potential. Timing and choices regarding contraception and pregnancy require discussion with the clinician.
Breastfeeding is generally not recommended during Nolvadex therapy. A discussion with the clinician about alternatives during the treatment period is advised.
Periodic liver function tests may be ordered during treatment. Any symptoms suggesting liver problems, such as unusual fatigue, abdominal pain, or jaundice, require prompt medical evaluation.
Unused or expired Nolvadex should be disposed of according to local guidelines. A pharmacist can provide safe disposal instructions appropriate for the jurisdiction.
Interactions may occur with hormonal therapies. The clinician will advise on compatible contraception options during Nolvadex therapy and whether alternatives are preferable.
Age-related changes in drug metabolism and risk factors for blood clots or bone health may influence monitoring and dosing considerations. Regular follow-up is essential for safety and efficacy in older patients.
All new medications should be reported to the treating team, including OTC products and supplements. A pharmacist will review potential interactions and advise on necessary precautions or adjustments.
Post-treatment monitoring plans vary. In some cases, maintenance therapy or extended surveillance may continue under medical guidance. Questions about long-term use should be discussed with the oncology team.
14–21 days. Free from C$275.49 .
5–9 days. C$41.32
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
